Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis
M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, P. Tabarsi, F. Mohammadi, M. R. Masjedi, A. A. Velayati (Tehran, Tabriz, Islamic Republic Of Iran)
Source: Annual Congress 2005 - Biological and treatment aspects of tuberculosis
Session: Biological and treatment aspects of tuberculosis
Session type: Poster Discussion
Number: 2897
Disease area: Respiratory infections
Abstract Introduction: Antioxidants have significant effects in pulmonary Tuberculosis (TB) recovery. Aim: We have evaluated vitamin supplement therapy on malondialdehyde (MDA) levels as lipid peroxidation marker in TB course.Method: We have conducted a clinical trial study. So, patients have selected as case and same number for control. Inclusion criteria were documented smear positive pulmonary TB and adult hood and new case. We exclude, all Extra-pulmonary TB and smear negative TB. Case group received vitamin A, or vitamin A with Vitamin E and C. Both groups received anti TB as WHO recommendation. The serum level of vitamin A and E have measured by HPLC and Vitamin C by 2,4 dinitrophenilhydralazine method. Data have analyzed by SPSS.Results : MDA serum levels in case group and control were 4 ± .7 nmol/L And 3.6 ±1 nmol/L respectively.(P=0.572) The serum level of MDA after our intervention was 3.3 ± .7 in Vitamin A group and 3.9±1.1 in control group. The MDA levels differences were significant in case group (P = .018) but no differences has showed in control group. (P=.308)Conclusion: There is significant decrease in lipid stress oxidative process in vitamin supplement therapy group. It may help to prevent more tissue damage in tuberculosis disease course.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, P. Tabarsi, F. Mohammadi, M. R. Masjedi, A. A. Velayati (Tehran, Tabriz, Islamic Republic Of Iran). Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 2897
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Dynamics of carbohydrate metabolism in patients with destructive pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Vitamin C levels in Indian patients with active pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Iron status in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005
Serum level of vitamin D3 before and after treatment in pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012
Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Nutritional deficiency in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10 Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Lipid peroxidation and antioxidative enzymes in patients with COPD: relationship to pulmonary hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Diet related vitamin D deficiency and reactivation of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 416s Year: 2004
Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011
Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Are the thiol/disulfide redox status and HDL cholesterol levels associated with pulmonary embolism? Source: International Congress 2017 – Pulmonary embolism Year: 2017
Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Serum lipid profile and zinc content in sera and pulmonary tissue of rabbits with pulmonary emphysema Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009
Vitamin B12 deficiency, extrathoracic airway mucosa and dysfunction Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Experimental emphysema: influence of tocopherol on serum iron content and lipid profile Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 19: 1119-1123 Year: 2002